We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Induction of Labor in Intrahepatic Cholestasis of Pregnancy (ILICP)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01381939
Recruitment Status : Completed
First Posted : June 27, 2011
Last Update Posted : June 27, 2011
Information provided by:
Karolinska Institutet

Brief Summary:
Induction of Labour in Intrahepatic Cholestasis of Pregnancy (ICP) has become a common procedure in management of ICP to avoid fetal complications. Surprisingly, this empirical approach has not been evaluated as to delivery complications and fetal outcome as yet. The investigators now examine weather ICP affects (i) delivery procedures chosen, in particular the incidence of caesarian section, (ii)fetal and maternal outcome in induced labor, and (iii)possible impact of bile acids and UDCA treatment in a retrospective cohort study based on approximately 5000 induced deliveries at Danderyd Hospital, Karolinska Institutet, Stockholm. The investigators analyze data on on previous deliveries, BMI, medical history and medical book data. Primary endpoint is the risk of caesarian section.

Condition or disease
Intrahepatic Cholestasis

Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Cohort
Time Perspective: Retrospective
Official Title: Induction of Labor in Intrahepatic Cholestasis of Pregnancy
Study Start Date : January 2000
Primary Completion Date : December 2006
Study Completion Date : April 2010

Induction of labor in ICP
Induction of laborin women with ICP
Induction of labor in women with no ICP
ICP and spontanius delivery

Primary Outcome Measures :
  1. Cesarean section [ Time Frame: 32 to 40 weeks ]

Secondary Outcome Measures :
  1. Bleeding [ Time Frame: 32 to 40 weeks ]
  2. Abruptio placentae [ Time Frame: 32 to 40 weeks ]
  3. APGAR [ Time Frame: 32 to 40 weeks ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Swedish women affected by ICP delivering at Danderyd Hospital between year 2000-2006.

Inclusion Criteria:

  • ICP during pregnancy and induction of labor ICP and spontaneous delivery No ICP but induction of labor

Exclusion Criteria:

  • No ICP spontaneous delivery
  • Elective caesarian section

Responsible Party: Prof Hanns-Ulrich Marschall, Sahlgrenska Academy, University of Gothenburg
ClinicalTrials.gov Identifier: NCT01381939     History of Changes
Other Study ID Numbers: 6647416
First Posted: June 27, 2011    Key Record Dates
Last Update Posted: June 27, 2011
Last Verified: March 2010

Keywords provided by Karolinska Institutet:
Intrahepatic Cholestasis of Pregnancy
Induction of labor
Caesarian section

Additional relevant MeSH terms:
Cholestasis, Intrahepatic
Pregnancy Complications
Bile Duct Diseases
Biliary Tract Diseases
Digestive System Diseases
Liver Diseases